Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-26

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved an original application for Ketorolac tromethamine from Leading Pharma, LLC, confirming the approval of a generic NSAID for short-term management o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)